AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...

Shares of AstraZeneca Pharma India Ltd., Pfizer Ltd., Biocon Ltd. and other pharma stocks shot up on Saturday as Finance Minister Nirmala Sitharaman announced the removal of customs duty on 36 drugs ...

AstraZeneca has abandoned a £450m investment ... s “discouraging” tax regime for a decision to build a £320m drug factory in Ireland rather than the UK. But in March 2024, Mr Hunt, the ...

Rachel Reeves was dealt yet another blow after AstraZeneca cancelled a planned £450 million investment in a vaccine manufacturing plant. The chancellor came under fire on GB News for "making an ...

"Liverpool City Region Combined Authority has not been party to the negotiations between government and AstraZeneca, which have taken place over many months," he said. "However, we have worked ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

While AstraZeneca confirmed no current jobs at the Speke site would be affected, the cancellation raises questions about Britain's investment climate. The Chancellor has recently attempted to shift ...

Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. "Several factors ...

AstraZeneca has pulled out of plans to build a new £450m facility in Liverpool. AstraZeneca, which produced one of the Covid-19 jabs, has an existing site on Renaissance Way, Speke and during the ...

the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Dato-DXd marketed with AstraZeneca (NASDAQ:AZN) as a late-line option for certain cases of breast cancer. Issuing a so-cal ...

The treatment pairs a tumor-killing drug with an antibody designed to home in on cancerous tissue. In December, Astra and Daiichi withdrew an application in the EU for the drug to treat a type of ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...